在初级医疗中采用非药物非手术干预治疗男性泌尿系统症状(TRIUMPH)与常规照护比较:整群随机对照试验研究方案
TRIUMPH是一项在英格兰30家NHS全科诊所开展的两臂整群随机对照试验,比较标准化手册化照护干预与常规照护对男性下尿路症状的效果。干预包括标准化建议手册及护士/医疗助理在评估后指导患者使用相关章节,并在12周内随访;主要结局为同意后12个月的患者报告国际前列腺症状评分(IPSS)。
要点
- TRIUMPH为两臂整群随机对照试验,在英格兰30家NHS全科诊所开展,按1:1随机分配至干预或常规照护路径。
- 干预为标准化手册化照护:护士/医疗助理评估泌尿症状后发放建议手册并指导相关章节,12周内随访以促进依从。
- 主要结局为同意后12个月的患者报告国际前列腺症状评分(IPSS)。
核心结论
- TRIUMPH旨在确定初级医疗中标准化手册化照护干预是否较常规照护对男性下尿路症状取得更优的症状结局。
研究设计与样本
- 两臂整群随机对照试验,在英格兰30家NHS全科诊所开展,按1:1随机分配至TRIUMPH干预或常规照护路径。
- 主要分析按意向性治疗原则进行。
关键数值与推荐
- 主要结局为同意后12个月的患者报告国际前列腺症状评分(IPSS)。
- 次要结局包括成本效果、下尿路症状患者报告结局、生活质量以及患者和医疗专业人员对干预的接受度与体验。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lower urinary tract symptoms (LUTS) can relate to urinary storage or voiding. In men, the prevalence and severity of LUTS increases with age, with a significant impact on quality of life. The majority of men presenting with LUTS are managed by their general practitioner (GP) in the first instance, with conservative therapies recommended as the initial treatment. However, the provision of conservative therapies in primary care is variable and can be time and resource limited. GPs require practical resources to enhance patient engagement with such interventions. TRIUMPH aims to determine whether a standardised and manualised care intervention delivered in primary care achieves superior symptomatic outcome for LUTS versus usual care. METHODS/DESIGN: TRIUMPH is a two-arm, cluster randomised controlled trial (RCT) being conducted in 30 National Health Service (NHS) general practices in England. The TRIUMPH intervention comprises a standardised LUTS advice booklet developed for the trial with patient and healthcare professional (HCP) consultation. The booklet is delivered to patients by nurses/healthcare assistants following assessment of their urinary symptoms. Patients are directed to relevant sections of the booklet, providing the manualised element of the intervention. To encourage adherence, HCPs provide follow-up contacts over 12 weeks. Practices are randomised 1:1 to either deliver the TRIUMPH intervention or a usual care pathway. The patient-reported International Prostate Symptom Score (IPSS) at 12 months post consent is the primary outcome. Secondary outcomes include cost-effectiveness, patient-reported outcomes on LUTS, quality of life, and patient and HCP acceptability and experience of the intervention. Primary analyses will be conducted on an intention-to-treat basis. DISCUSSION: It is unclear whether conservative therapies for male LUTS are effectively delivered in primary care using current approaches. This can lead to men being inappropriately referred to secondary care or experiencing persistent symptoms. Primary care, therefore, holds the key to effective treatment for these men. The TRIUMPH intervention, through its standardised and manualised approach, has been developed to support GP practices in delivering effective conservative care. This pragmatic, cluster RCT should provide robust evidence in a primary-care setting to inform future guidelines. TRIAL REGISTRATION: ISCRTN registry, ID: ISRCTN11669964 . Registered on 12 April 2018.
引用
- Frost J, Lane JA, Cotterill N, et al. TReatIng Urinary symptoms in Men in Primary Healthcare using non-pharmacological and non-surgical interventions (TRIUMPH) compared with usual care: study protocol for a cluster randomised controlled trial. Trials. 2019. PMID: 31477160. doi:10.1186/s13063-019-3648-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。